Recruitment

Recruitment Status
Enrolling by invitation
Estimated Enrollment
6

Inclusion Criteria

Individuals with normal or mild cognitive impairment.
All patients will have responsivity to levodopa.
Parkinson's Disease (PD) patients in whom optimal medical therapy has failed.
...
Individuals with normal or mild cognitive impairment.
All patients will have responsivity to levodopa.
Parkinson's Disease (PD) patients in whom optimal medical therapy has failed.
All patients will be enrolled from the practice of the primary investigator.

Exclusion Criteria

Clinically significant dementia
Previous brain surgery including pallidotomy or thalamotomy
Previous placement of other implantable devices
...
Clinically significant dementia
Previous brain surgery including pallidotomy or thalamotomy
Previous placement of other implantable devices
Other significant neurological or psychiatric disease

Summary

Conditions
  • Deep Brain Stimulation
  • Parkinson's Disease
Type
Interventional
Design
  • Allocation: N/A
  • Intervention Model: Single Group Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 40 years and 80 years
Gender
Both males and females

Inclusion Criteria

Individuals with normal or mild cognitive impairment.
All patients will have responsivity to levodopa.
Parkinson's Disease (PD) patients in whom optimal medical therapy has failed.
...
Individuals with normal or mild cognitive impairment.
All patients will have responsivity to levodopa.
Parkinson's Disease (PD) patients in whom optimal medical therapy has failed.
All patients will be enrolled from the practice of the primary investigator.

Exclusion Criteria

Clinically significant dementia
Previous brain surgery including pallidotomy or thalamotomy
Previous placement of other implantable devices
...
Clinically significant dementia
Previous brain surgery including pallidotomy or thalamotomy
Previous placement of other implantable devices
Other significant neurological or psychiatric disease

Tracking Information

NCT #
NCT01563341
Collaborators
Not Provided
Investigators
  • Principal Investigator: Ryan Uitti, M.D. Mayo Clinic
  • Ryan Uitti, M.D. Mayo Clinic